Hints and tips:
Related Special Reports
...Poland’s health minister Adam Niedzielski said the deal favoured pharmaceutical companies, not EU citizens. He also demanded the confidential contract be published....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...In May, the Pharmaceutical Supply Chain Initiative, a lobby set up by large pharmaceutical companies, said its members should stop sourcing blood from the two Asian horseshoe crab species most at risk....
...Janssen is the pharmaceutical division of J&J....
...Adams, who regularly confers with Bloomberg, has sought to reignite the ambition since taking office in January....
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
...A booster shot of Johnson & Johnson’s Covid-19 vaccine produced a strong and rapid antibody response against the virus, the pharmaceutical company said on Wednesday....
...This is not just a recent phenomenon: Adam quotes Mark Jones, former director of London’s V&A, on Richard Wallace (1818-90), founder of the Wallace Collection, who “was an outsider, because of being illegitimate...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...“Although [mRNA vaccines] have always shown promise, the infrastructure and experience with large scale manufacturing wasn’t there,” says Adam Barker, an analyst at Shore Capital....
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
...Kate Adams, Apple’s chief counsel, called the verdict “a huge win”, pointing to the court’s ruling that “Apple is not a monopolist under ‘either federal or state antitrust laws’”....
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
..., J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the global efforts to fight Covid-19 . . ....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...Their pipeline is dependent on it,” said Adam Barker, healthcare equity analyst at Shore Capital. In contrast: “AstraZeneca is not a vaccine player at all....
...“At present, no clear causal relationship has been established between these rare events and the Janssen [J&J] Covid-19 vaccine,” it said, adding that it was working closely with experts and regulators to...
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
..., J&J’s pharmaceutical division....
...“The acquisition was driven by the significant opportunity seen in nipocalimab, along with the scientific capability Janssen is acquiring with the Momenta team,” J&J said in a statement....
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase-3 trial....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...It’s the most accessible of all the vaccines and so will still be used widely if approved,” said Shore Capital’s Adam Barker....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
International Edition